Profile: Access Pharmaceuticals, Inc. specializes in pharmaceutical products. Our product line includes MuGard™, ProLindac, Cobalamin mediated oral drug delivery, Thiarabine and CobaCyte - Cobalamin. Our MuGard™ is a viscous, mucoadhesive rinse which provides a protective coating to the oral mucosa. In a comparison of patients undergoing standard care with patients using MuGard™, the incidence and severity of mucositis was significantly lower for the MuGard™ group. Our ProLindac is Access Pharmaceutical's leading oncology drug, which has completed a phase 2 monotherapy study in ovarian cancer patients. It is a therapeutic drug, previously known as AP5346. It utilizes a safe, water-soluble nanoparticulate system to deliver DACH platinum (the active moiety of oxaliplatin) to tumors.

FDA Registration Number: 3008334517